Thought Leadership

Improving America's Health V

Since 1995, PwC has periodically surveyed the life sciences industry on its working relationship with its chief regulatory agency, the US Food and Drug Administration (FDA). This series comprising five surveys is meant to provide insight to FDA and the industry on how to expand trust and build on their relationship. The most recent survey, concluded in summer 2010, was undertaken jointly by PwC's Pharmaceuticals and Life Sciences R&D Advisory Services team and BIOCOM, the world's largest regional life sciences association, representing 550 Southern California life sciences companies.
Improving America's Health V

Related material

Improving America's Health V Podcast

Improving America's Health V Podcast

Listen to podcast

Improving America's Health V Podcast

Improving America's Health V Podcast

Michael Mentesana, US Pharmaceuticals and Life Sciences R&D Advisory Services leader for PwC, and Joseph Panetta President and CEO of BIOCOM, discuss findings from Improving America's Health V: A Study of the Working Relationship Between the Life Sciences Industry and FDA. The podcast concludes with perspectives from Randall Woods, CEO of Sequel Pharmaceuticals, on what the findings mean to industry.

If you have difficulty accessing this report, please update Adobe Reader.

Look for papers, articles, and case studies. See all thought leadership.